Analyst Conference Summaries

Biotechnology Investor Aids

Ionis Pharmaceuticals
IONS

I plan to being coverage of Ionis with the Q2 2017 conference call. I own stock in a rival, Alnylam Pharmaceuticals (ALNY).

conference date: not yet scheduled

 

2017

 
 
 
 
 

O (O) is a -stage biotechnology company specializing in

Ionis Pharmaceuticals web site

Ionis Pharmaceuticals investor relations


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 INO
 INTC
 ISRG
 JUNO
 MACK
 MCHP
 MYL.
 NVDA
 PLX
 REGN
 SGEN
 XLNX
 XLRN
 
 

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2017 William P. Meyers